{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:15:25Z","timestamp":1763399725216,"version":"3.37.3"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K12 CA090628"],"award-info":[{"award-number":["K12 CA090628"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>49d is a surface integrin that is expressed on chronic lymphocytic leukaemia (<jats:styled-content style=\"fixed-case\">CLL<\/jats:styled-content>) cells, and strongly correlates with more aggressive disease. Given its association with cell\u2010cell adhesion and leucocyte trafficking, we hypothesized that patients with high <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>49d expression would experience a clinical course dominated by lymphadenopathy. <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>49d expression was measured by flow cytometry and considered positive if expressed by \u226530% of <jats:styled-content style=\"fixed-case\">CLL<\/jats:styled-content> cells. The study included 797 newly diagnosed <jats:styled-content style=\"fixed-case\">CLL<\/jats:styled-content>\/small lymphocytic leukaemia patients; 279 (35%) were <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>49d positive. <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>49d\u2010positive patients were more likely to present with lymphadenopathy (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0\u00b7001); a finding that persisted after adjusting for fluorescence <jats:italic>in\u00a0situ<\/jats:italic> hybridisation (<jats:styled-content style=\"fixed-case\">FISH<\/jats:styled-content>) and <jats:italic><jats:styled-content style=\"fixed-case\">IGHV<\/jats:styled-content><\/jats:italic> mutation status [odds ratio (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>) 2\u00b751; 95% confidence interval (<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) 1\u00b764\u20133\u00b783; <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0\u00b7001]. Among <jats:styled-content style=\"fixed-case\">CLL<\/jats:styled-content> Rai 0 patients, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>49d positivity was associated with shorter time to development of lymphadenopathy (3\u00b72\u00a0years vs not reached, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0\u00b701). This association was maintained after adjusting for either <jats:styled-content style=\"fixed-case\">FISH<\/jats:styled-content> [hazard ratio (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>) 2\u00b718; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 1\u00b725\u20133\u00b781; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0\u00b7006) or <jats:italic><jats:styled-content style=\"fixed-case\">IGHV<\/jats:styled-content><\/jats:italic> status (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 2\u00b702; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 1\u00b711\u20133\u00b769; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0\u00b702) individually, but was attenuated when adjusting by both (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 1\u00b772; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0\u00b788\u20133\u00b738; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0\u00b711).These data demonstrate that <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>49d\u2010positive <jats:styled-content style=\"fixed-case\">CLL<\/jats:styled-content> patients experience a disease course dominated by lymphadenopathy. These findings could have implications for therapy selection and disease monitoring.<\/jats:p>","DOI":"10.1111\/bjh.14647","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T06:08:46Z","timestamp":1491545326000},"page":"99-105","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["<scp>CD<\/scp>49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia"],"prefix":"10.1111","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-1459","authenticated-orcid":false,"given":"Paolo","family":"Strati","sequence":"first","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer A.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari G","family":"Chaffee","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara J.","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Slager","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy G.","family":"Call","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ding","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane F.","family":"Jelinek","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil E.","family":"Kay","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tait D.","family":"Shanafelt","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01626.x"},{"key":"e_1_2_8_3_1","first-page":"147","article-title":"Expression of adhesion molecules on leukemic B cells from chronic lymphocytic leukemia patients with predominantly splenic manifestations","volume":"6","author":"Bairey O.","year":"2004","journal-title":"The Israel Medical Association Journal: IMAJ"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1182\/blood-2006-10-051110","article-title":"Comprehensive characterization of IGHV3\u201021\u2010expressing B\u2010cell chronic lymphocytic leukemia: an Italian multicenter study","volume":"109","author":"Bomben R.","year":"2007","journal-title":"Blood"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-233692"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1634"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08725.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.8515"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-333682"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.888"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01454.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20593"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.7.2516"},{"key":"e_1_2_8_14_1","first-page":"1331","article-title":"Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages","volume":"10","author":"Eksioglu\u2010Demiralp E.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20553"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083830"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-092486"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09191.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583518"},{"key":"e_1_2_8_21_1","first-page":"104","article-title":"Expression of adhesion molecules in chronic B\u2010cell lymphoproliferative disorders","volume":"83","author":"Lucio P.J.","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.10.022"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.02.004"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-257758"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-683128"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.308"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930801)72:3<894::AID-CNCR2820720339>3.0.CO;2-A"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403975"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1218-z"},{"key":"e_1_2_8_30_1","unstructured":"R Core Team(2015).R: A language and environment for statistical computing. R Foundation for Statistical Computing Vienna Austria. URLhttps:\/\/www.R-project.org\/."},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109249"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-552307"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e31826cda2d"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.2.624"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06965.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.02.001"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.10.2.12168"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02294.x"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.8.2977"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-544569"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20269"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2005.07.004"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20570"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4173"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.369"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-507335"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.14647","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.14647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T13:57:04Z","timestamp":1696341424000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.14647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/bjh.14647"],"URL":"https:\/\/doi.org\/10.1111\/bjh.14647","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"assertion":[{"value":"2016-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}